Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474000 | SCV000541978 | likely benign | Neurofibromatosis, type 1 | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318983 | SCV001184006 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2022-01-25 | criteria provided, single submitter | clinical testing | The p.R1441W variant (also known as c.4321C>T), located in coding exon 32 of the NF1 gene, results from a C to T substitution at nucleotide position 4321. The arginine at codon 1441 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000474000 | SCV002560417 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003128802 | SCV003805935 | uncertain significance | not provided | 2022-08-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25486365, 22807134) |